| 000 | 01654 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516014102.0 | ||
| 264 | 0 | _c20110414 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2010.11.038 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGilbert, Adam M | |
| 245 | 0 | 0 |
_a3-(Pyridin-2-yl-ethynyl)benzamide metabotropic glutamate receptor 5 negative allosteric modulators: hit to lead studies. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cJan 2011 |
||
| 300 |
_a195-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAllosteric Regulation |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnxiety Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aBenzamides _xchemistry |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aHigh-Throughput Screening Assays |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPyridines _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aReceptor, Metabotropic Glutamate 5 |
| 650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xchemistry |
| 700 | 1 | _aBursavich, Matthew G | |
| 700 | 1 | _aLombardi, Sabrina | |
| 700 | 1 | _aAdedoyin, Adedayo | |
| 700 | 1 | _aDwyer, Jason M | |
| 700 | 1 | _aHughes, Zoe | |
| 700 | 1 | _aKern, Jeffrey C | |
| 700 | 1 | _aKhawaja, Xavier | |
| 700 | 1 | _aRosenzweig-Lipson, Sharon | |
| 700 | 1 | _aMoore, William J | |
| 700 | 1 | _aNeal, Sarah J | |
| 700 | 1 | _aOlsen, Michael | |
| 700 | 1 | _aRizzo, Stacey J Sukoff | |
| 700 | 1 | _aSpringer, Dane | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 21 _gno. 1 _gp. 195-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2010.11.038 _zAvailable from publisher's website |
| 999 |
_c20418411 _d20418411 |
||